Compare Alcon AG (ALC) vs iShares China Large-Cap ETF (FXI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs iShares China Large-Cap ETF — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while iShares China Large-Cap ETF trades at $33.41. The key difference: Alcon AG pays a 0.54% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals.
| ALC | FXI | |
|---|---|---|
Market Cap | $32.69B | — |
Sector | Health | — |
52-Week High | $92.22 | $41.75 |
52-Week Low | $62.02 | $31.59 |
Enterprise Value | $36.28B | — |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
The iShares China Large-Cap ETF (FXI) trades at $32.51, up 1.88% on the day, while technical indicators signal a bearish trend with moving averages and overall momentum favoring sellers. Recent news highlights China's AI and chip sector driving factory rebounds and IPO activity, though broader sentiment on Chinese equities remains mixed, with some analysts labeling them as potential value traps. The ETF shows neutral oscillator readings with key support at $32 and resistance at $33.
The outlook for FXI is clouded by structural macroeconomic headwinds in China, including deflationary pressures and geopolitical tensions with the U.S., which offset potential opportunities from the country's massive AI infrastructure investment plans. While the sector benefits from technology self-reliance initiatives, persistent risks to corporate profitability and valuation compression suggest a cautious approach for equity investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →
